![Detection of MET amplification by droplet digital PCR in peripheral blood samples of non-small cell lung cancer | Journal of Cancer Research and Clinical Oncology Detection of MET amplification by droplet digital PCR in peripheral blood samples of non-small cell lung cancer | Journal of Cancer Research and Clinical Oncology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00432-022-04048-4/MediaObjects/432_2022_4048_Fig1_HTML.png)
Detection of MET amplification by droplet digital PCR in peripheral blood samples of non-small cell lung cancer | Journal of Cancer Research and Clinical Oncology
![MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression. | Semantic Scholar MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/63e4b99a551c5b6051e8d2ab1eb946039d127902/3-Figure1-1.png)
MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression. | Semantic Scholar
![Frontiers | Prognosis and Concurrent Genomic Alterations in Patients With Advanced NSCLC Harboring MET Amplification or MET Exon 14 Skipping Mutation Treated With MET Inhibitor: A Retrospective Study Frontiers | Prognosis and Concurrent Genomic Alterations in Patients With Advanced NSCLC Harboring MET Amplification or MET Exon 14 Skipping Mutation Treated With MET Inhibitor: A Retrospective Study](https://www.frontiersin.org/files/Articles/649766/fonc-11-649766-HTML/image_m/fonc-11-649766-g001.jpg)
Frontiers | Prognosis and Concurrent Genomic Alterations in Patients With Advanced NSCLC Harboring MET Amplification or MET Exon 14 Skipping Mutation Treated With MET Inhibitor: A Retrospective Study
![Cancers | Free Full-Text | Targeting MET Amplification: Opportunities and Obstacles in Therapeutic Approaches Cancers | Free Full-Text | Targeting MET Amplification: Opportunities and Obstacles in Therapeutic Approaches](https://pub.mdpi-res.com/cancers/cancers-15-04552/article_deploy/html/images/cancers-15-04552-g001.png?1694680632)
Cancers | Free Full-Text | Targeting MET Amplification: Opportunities and Obstacles in Therapeutic Approaches
![Unraveling the Significance of MET Focal Amplification in Lung Cancer: Integrative NGS, FISH, and IHC Investigation - Modern Pathology Unraveling the Significance of MET Focal Amplification in Lung Cancer: Integrative NGS, FISH, and IHC Investigation - Modern Pathology](https://www.modernpathology.org/cms/attachment/ee9cbd11-429d-4e78-b972-ea791b983c1b/gr1.jpg)
Unraveling the Significance of MET Focal Amplification in Lung Cancer: Integrative NGS, FISH, and IHC Investigation - Modern Pathology
![MET Signaling: Novel Targeted Inhibition and Its Clinical Development in Lung Cancer - ScienceDirect MET Signaling: Novel Targeted Inhibition and Its Clinical Development in Lung Cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S155608641533255X-gr1.jpg)
MET Signaling: Novel Targeted Inhibition and Its Clinical Development in Lung Cancer - ScienceDirect
![MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors | Experimental Hematology & Oncology | Full Text MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors | Experimental Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40164-021-00245-y/MediaObjects/40164_2021_245_Fig3_HTML.png)
MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors | Experimental Hematology & Oncology | Full Text
![MET-dependent solid tumours — molecular diagnosis and targeted therapy | Nature Reviews Clinical Oncology MET-dependent solid tumours — molecular diagnosis and targeted therapy | Nature Reviews Clinical Oncology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41571-020-0377-z/MediaObjects/41571_2020_377_Fig1_HTML.png)
MET-dependent solid tumours — molecular diagnosis and targeted therapy | Nature Reviews Clinical Oncology
![MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer | Journal of Hematology & Oncology | Full Text MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13045-019-0759-9/MediaObjects/13045_2019_759_Fig2_HTML.png)
MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer | Journal of Hematology & Oncology | Full Text
![Detection of MET amplification by droplet digital PCR in peripheral blood samples of non-small cell lung cancer | Journal of Cancer Research and Clinical Oncology Detection of MET amplification by droplet digital PCR in peripheral blood samples of non-small cell lung cancer | Journal of Cancer Research and Clinical Oncology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00432-022-04048-4/MediaObjects/432_2022_4048_Fig2_HTML.png)